Paper Details

  1. Home
  2. Paper Details

[The efficacy of ethambutol compared to streptomycin in the initial quadruple phase of short-term regimens].

Author: AnastasatuC, MaricaC, MitreaM, RohanI

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A study of 120 patients with tuberculosis compared two short-term treatment regimens: one containing streptomycin (SM) and the other containing ethambutol (EMB). Both regimens were equally effective in clearing bacteria from sputum within 2 months. However, the study recommends further research to compare these regimens with a shorter, triple-drug regimen over a longer follow-up period.
Paper Details　
Original Abstract of the Article :
In order to test comparatively SM and EMB efficacies within quadruple regimens of short-term chemotherapy, two groups of patients with pulmonary tuberculosis at first treatment, sputum positive under microscopic examination, were constituted through randomization. One group (59 cases) was submitted ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/1342819

データ提供：米国国立医学図書館（NLM）

Exploring the Desert of Tuberculosis Treatment: A Comparative Study

The vast and unforgiving desert of tuberculosis (TB) treatment is constantly evolving. This study delves into the comparative effectiveness of two important anti-TB drugs, streptomycin (SM) and ethambutol (EMB), within quadruple regimens of short-term chemotherapy. Like a skilled explorer testing different routes across a desert, researchers randomly assigned 120 patients with TB to two groups, each receiving a distinct quadruple regimen.

The Journey is Similar: Similar Efficacy Found

The study revealed that both SM and EMB demonstrated similar efficacy within the quadruple regimens. This finding is like discovering that two different paths lead to the same oasis, offering different experiences but ultimately reaching the same destination. However, the authors acknowledge that the results may be influenced by the bactericidal action of other drugs in the regimens.

Navigating the Dunes: The Need for Further Research

While the study offers valuable insights into the efficacy of SM and EMB within quadruple regimens, it emphasizes the need for further research to compare the triple regimen RHZ 2/7 with the quadruple RHSZ 2/7 and RHZE 2/7 over a longer period. This is like understanding that a longer journey might require more careful navigation and planning to ensure a successful outcome. Further research is essential for optimizing treatment strategies and ensuring the best possible outcomes for patients with TB.

Dr. Camel's Conclusion

This study provides an important step in our understanding of the efficacy of different anti-TB drugs. While the findings suggest that SM and EMB have comparable efficacy within quadruple regimens, further research is crucial to refine treatment strategies and optimize outcomes for patients battling this challenging disease.

Date :
  1. Date Completed 1994-02-23
  2. Date Revised 2016-10-21
Further Info :

Pubmed ID

1342819

DOI: Digital Object Identifier

1342819

SNS
PICO Info
in preparation
Languages

Romanian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.